When: March 6, 2019: 6:30 pm – 9:30 pm
Come and network at one of the most exciting 3D Printing events in Chicago this year. Join a panel of experts on a variety of healthcare 3D printing innovations, ranging from 3D printed anatomical models, metal 3D printed implants, to biomaterials for 3D printing, and bioprinting in cardiac tissue regeneration.
6:30-7:00 PM Registration/Networking
7:00-7:15 PM NixonPeabody LLP sponsor intro /3DHEALS community manager Nilay Parikh intro
7:15-7:25 PM Adam Jakus (Dimension Inx)
7:25-7: 30 PM Q&A
7:30-7: 40 PM Steven Morris (BIOLIFE4D)
7:40-7:45 PM Q&A
7:45-7:55 PM Stephen Anderson (Renishaw)
7:55-8:00 PM Q&A
8:00-8:10 PM Alejandro A. Espinoza Orías, PhD (Rush Medical College)
8:10-8:15 PM Q&A
8:15-8:45 PM Panel Q&A
8:45-9:30 PM Networking and wrap-up
(After event location will be announced to continue the conversations.)
Adam Jakus, Ph.D.: is the co-founder and Chief Technology of Dimension Inx LLC, a start-up developing transformative advanced manufacturing materials and processes for medical and non-medical spaces. Adam received his BS and MS degrees in Materials Science and Engineering from Georgia Tech, where he worked on the development and testing of new energetic material systems. In 2010, he began working at Northwestern University with Dimension Inx’s other co-founder, Ramille Shah, Ph.D. While at Northwestern, Adam invented and developed an entirely new, materials-centric approach to 3D-printing and advanced manufacturing, now referred to as 3D-Painting, and hundreds of new 3D-printable materials for medical and non-medical purposes. These materials include, but are not limited to the high tissue and organ regenerative Hyperelastic Bone™, 3D-Graphene, Tissue Papers, and Fluffy-X. With approximately 10 years and many thousands of hours of bioprinting and tissue regenerative 3D-Printing experience, Adam leads the field, providing expertise to several not-for-profit bodies looking to establish guidelines, guidance, and certifications related to the emerging fields of tissue and organ fabrication. He is the author of numerous granted and pending patents, high impact medical and non-medical publications, book chapters, and editorials related to advanced manufacturing and 3D-printing of biomaterials and non-materials. (Read our interview with Adam Jakus.)
Steven Morris: BIOLIFE4D Founder and CEO Steven Morris possess more than 20 years of extensive experience in precision manufacturing, including 15 years serving as President of privately-held Inland Midwest Corporation (IMC) where he led the company’s transformation into a premier, state-of-the-art facility catering exclusively to the medical technologies industry. After several years of high profitability, Steven negotiated a successful exit strategy and sold the company in 2011. After remaining on as President for over two years, he left and started BIOLIFE4D, an emerging biotech company working on the technology to bioengineer a human heart viable for transplantation using a patient’s own cells. His diverse and comprehensive knowledge of medical devices, processes optimization, and medical technologies will be extremely beneficial to the success of BIOLIFE4D. (Read our interview with Steven Morris.)
Additive Manufacturing Business Development Manager – USA at Renishaw Inc
Stephen Anderson PhD CEng MBCS MInstP obtained his doctorate from the University of Lancaster, UK (1993) and worked at the University of Bristol, UK in research and as Academic Director of Computing. He joined Renishaw in 2000 as Internet Development Manager switching into Group Engineering in 2007 and becoming Group Software Director in 2011. With 17 years’ systems software experience, he delivered much of the Group’s Software portfolio across its Industrial Metrology, Healthcare and Additive Manufacturing businesses, from probing software to neurosurgery and Renishaw’s own AM build preparation software QuantAM. In 2017 Stephen took up a new role as AM Business Development Manager – USA where he is responsible for all aspects of Renishaw’s AM product line in the US.
Dr. Espinoza is the director of Orthopedic Surgery 3-D Printing Laboratory, assistant professor of Department of Orthopedic Surgery at Rush Medical College, and assistant director of Spine Biomechanics Laboratory.
Postdoctoral fellowship, McKay Orthopaedic Research Lab, Perelman School of Medicine, University of Pennsylvania, 2007
Ph.D., aerospace and mechanical engineering, University of Notre Dame, 2005
MSc, mechanical engineering, University of Notre Dame, 2003
BSc (Licentiate), mechanical engineering, Universidad Mayor de San Andres, Bolivia, 1999
The Spine Biomechanics Laboratory at Rush is dedicated primarily to the study of the motion and loading conditions of the human spine. Both cervical and lumbar spine are recurrent work topics as we develop new methodologies to link abnormal motion patterns and loads that are thought to be precursors for facet joints and intervertebral disc degeneration.
Our approach is based on a unique combination of novel musculoskeletal image data processing methods, human motion analysis, and experimental biomechanics. The techniques and instrumentation developed in the laboratory have been applied successfully to both to research as well as implant testing studies.
Our expertise with the spine has also lead to studies in other joints such as the hip, knee, and shoulder. Our collaborations with clinician researchers from Midwest Orthopedics at Rush have led us to develop experiments to assess joint instability and cartilage qualitative studies in vitro.
This leads to another major area of work which is the study of hip biomechanics in Femoroacetabular Impingement. This bony deformity is not well characterized and we are working on developing structure-function relationships both at the organ and subject level.
We are pioneering the use of 3-D printing (also called additive manufacturing) in an academic medical center not only for anatomical models but to create functional models to be used in biomechanics research.
Thanks to our sponsor:
Thanks to our Media Partner: